{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:45:20Z","timestamp":1791049520956,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>These guidelines aim to support magnetic resonance imaging (MRI) diagnosis in patients receiving anti-amyloid \u03b2 (A\u03b2) antibody treatment without restricting treatment eligibility.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>These guidelines were collaboratively established by Japan Radiological Society, The Japanese Society of Neuroradiology, and Japanese Society for Magnetic Resonance in Medicine by reviewing existing literature and the results of clinical trials.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Facility standards should comply with the \u201cOptimal Use Promotion Guidelines\u201d of Japan, and physicians should possess comprehensive knowledge of amyloid-related imaging abnormalities (ARIA) and expertise in brain MRI interpretation. The acquisition of knowledge regarding amyloid-related imaging abnormalities, brain MRI, anti-A\u03b2 antibody introduction, and post-treatment diagnosis are also recommended.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>These guidelines facilitate the accurate diagnosis and effective management of ARIA; ensure the safe administration of anti-A\u03b2 drugs; and provide a framework for MRI facilities, includes staffing requirements and the use of MRI management systems.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11604-025-01773-x","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T03:35:06Z","timestamp":1745379306000},"page":"1231-1238","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Practical brain MRI guidelines for anti-A\u03b2 antibody treatment in early symptomatic Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"43","author":[{"given":"Shingo","family":"Kakeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohsuke","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harushi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya M.","family":"Tokumaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Working Group for Brain MRI Guidelines for Anti-A\u03b2 Antibody Treatment from The Japan Radiological Society, The Japanese Society for Neuroradiology, and The Japanese Society for Magnetic Resonance in Medicine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"1773_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/pcn.13681","volume":"78","author":"T Iwatsubo","year":"2024","unstructured":"Iwatsubo T. Development of disease-modifying therapies against Alzheimer\u2019s disease. Psychiatry Clin Neurosci. 2024;78:491\u20134. https:\/\/doi.org\/10.1111\/pcn.13681.","journal-title":"Psychiatry Clin Neurosci"},{"key":"1773_CR2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","volume":"21","author":"E Karran","year":"2022","unstructured":"Karran E, De Strooper B. The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics. Nat Rev Drug Discov. 2022;21:306\u201318. https:\/\/doi.org\/10.1038\/s41573-022-00391-w.","journal-title":"Nat Rev Drug Discov"},{"key":"1773_CR3","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41582-021-00520-w","volume":"17","author":"H Hampel","year":"2021","unstructured":"Hampel H, Cummings J, Blennow K, Gao P, Jack CR, Vergallo A. Developing the ATX(N) classification for use across the Alzheimer disease continuum. Nat Rev Neurol. 2021;17:580\u20139. https:\/\/doi.org\/10.1038\/s41582-021-00520-w.","journal-title":"Nat Rev Neurol"},{"key":"1773_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388:9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948.","journal-title":"N Engl J Med"},{"key":"1773_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/jamaneurol.2021.4161","volume":"79","author":"S Salloway","year":"2022","unstructured":"Salloway S, Chalkias S, Barkhof F, Burkett P, Barakos J, Purcell D, et al. Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease. JAMA Neurol. 2022;79:13\u201321. https:\/\/doi.org\/10.1001\/jamaneurol.2021.4161.","journal-title":"JAMA Neurol"},{"key":"1773_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(12)70015-7","volume":"11","author":"R Sperling","year":"2012","unstructured":"Sperling R, Salloway S, Brooks DJ, Tampieri D, Barakos J, Fox NC, et al. Amyloid-related imaging abnormalities in patients with Alzheimer\u2019s disease treated with Bapineuzumab: a retrospective analysis. Lancet Neurol. 2012;11:241\u20139. https:\/\/doi.org\/10.1016\/S1474-4422(12)70015-7.","journal-title":"Lancet Neurol"},{"key":"1773_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.dadm.2016.02.004","volume":"2","author":"C Carlson","year":"2016","unstructured":"Carlson C, Siemers E, Hake A, Case M, Hayduk R, Suhy J, et al. Amyloid-related imaging abnormalities from trials of solanezumab for Alzheimer\u2019s disease. Alzheimers Dement (Amst). 2016;2:75\u201385. https:\/\/doi.org\/10.1016\/j.dadm.2016.02.004.","journal-title":"Alzheimers Dement (Amst)"},{"key":"1773_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3233\/JAD-160216","volume":"57","author":"N Ketter","year":"2017","unstructured":"Ketter N, Brashear HR, Bogert J, Di J, Miaux Y, Gass A, et al. Central review of amyloid-related imaging abnormalities in two phase III clinical trials of Bapineuzumab in mild-to-moderate Alzheimer\u2019s disease patients. J Alzheimers Dis. 2017;57:557\u201373. https:\/\/doi.org\/10.3233\/JAD-160216.","journal-title":"J Alzheimers Dis"},{"key":"1773_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.14283\/jpad.2022.21","volume":"9","author":"J Barakos","year":"2022","unstructured":"Barakos J, Purcell D, Suhy J, Chalkias S, Burkett P, Marsica Grassi C, et al. Detection and management of amyloid-related imaging abnormalities in patients with Alzheimer\u2019s disease treated with anti-amyloid beta therapy. J Prev Alzheimers Dis. 2022;9:211\u201320. https:\/\/doi.org\/10.14283\/jpad.2022.21.","journal-title":"J Prev Alzheimers Dis"},{"key":"1773_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Jack CR, Black SE, Frosch MP, Greenberg SM, Hyman BT, et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer\u2019s Association research roundtable workgroup. Alzheimers Dement. 2011;7:367\u201385. https:\/\/doi.org\/10.1016\/j.jalz.2011.05.2351.","journal-title":"Alzheimers Dement"},{"key":"1773_CR11","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3174\/ajnr.A3500","volume":"34","author":"J Barakos","year":"2013","unstructured":"Barakos J, Sperling R, Salloway S, Jack C, Gass A, Fiebach JB, et al. MR imaging features of amyloid-related imaging abnormalities. AJNR Am J Neuroradiol. 2013;34:1958\u201365. https:\/\/doi.org\/10.3174\/ajnr.A3500.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1773_CR12","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.3174\/ajnr.A7586","volume":"43","author":"PM Cogswell","year":"2022","unstructured":"Cogswell PM, Barakos JA, Barkhof F, Benzinger TS, Jack CR, Poussaint TY, et al. Amyloid-related imaging abnormalities with emerging Alzheimer disease therapeutics: detection and reporting recommendations for clinical practice. AJNR Am J Neuroradiol. 2022;43:E19\u201335. https:\/\/doi.org\/10.3174\/ajnr.A7586.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1773_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s11604-018-0724-5","volume":"36","author":"KK Kumamaru","year":"2018","unstructured":"Kumamaru KK, Machitori A, Koba R, Ijichi S, Nakajima Y, Aoki S. Global and Japanese regional variations in radiologist potential workload for computed tomography and magnetic resonance imaging examinations. Jpn J Radiol. 2018;36:273\u201381. https:\/\/doi.org\/10.1007\/s11604-018-0724-5.","journal-title":"Jpn J Radiol"},{"key":"1773_CR14","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1093\/brain\/awad188","volume":"146","author":"H Hampel","year":"2023","unstructured":"Hampel H, Elhage A, Cho M, Apostolova LG, Nicoll JAR, Atri A. Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics. Brain. 2023;146:4414\u201324. https:\/\/doi.org\/10.1093\/brain\/awad188.","journal-title":"Brain"},{"key":"1773_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","volume":"16","author":"SM Greenberg","year":"2020","unstructured":"Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ. Cerebral amyloid angiopathy and Alzheimer disease: one peptide, two pathways. Nat Rev Neurol. 2020;16:30\u201342. https:\/\/doi.org\/10.1038\/s41582-019-0281-2.","journal-title":"Nat Rev Neurol"},{"key":"1773_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1001\/jamaneurol.2021.5205","volume":"79","author":"M Filippi","year":"2022","unstructured":"Filippi M, Cecchetti G, Spinelli EG, Vezzulli P, Falini A, Agosta F. Amyloid-related imaging abnormalities and \u03b2-amyloid-targeting antibodies: a systematic review. JAMA Neurol. 2022;79:291\u2013304. https:\/\/doi.org\/10.1001\/jamaneurol.2021.5205.","journal-title":"JAMA Neurol"},{"key":"1773_CR17","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.acra.2012.04.017","volume":"19","author":"S Kakeda","year":"2012","unstructured":"Kakeda S, Korogi Y, Hiai Y, Ohnari N, Sato T, Hirai T. Pitfalls of 3D FLAIR brain imaging: a prospective comparison with 2D FLAIR. Acad Radiol. 2012;19:1225\u201332. https:\/\/doi.org\/10.1016\/j.acra.2012.04.017.","journal-title":"Acad Radiol"},{"key":"1773_CR18","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1148\/radiol.2272020176","volume":"227","author":"KA Tong","year":"2003","unstructured":"Tong KA, Ashwal S, Holshouser BA, Shutter LA, Herigault G, Haacke EM, et al. Hemorrhagic shearing lesions in children and adolescents with posttraumatic diffuse axonal injury: improved detection and initial results. Radiology. 2003;227:332\u20139. https:\/\/doi.org\/10.1148\/radiol.2272020176.","journal-title":"Radiology"},{"key":"1773_CR19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1148\/radiology.212.3.r99se07793","volume":"212","author":"T Okuda","year":"1999","unstructured":"Okuda T, Korogi Y, Shigematsu Y, Sugahara T, Hirai T, Ikushima I, et al. Brain lesions: when should fluid-attenuated inversion-recovery sequences be used in MR evaluation? Radiology. 1999;212:793\u20138. https:\/\/doi.org\/10.1148\/radiology.212.3.r99se07793.","journal-title":"Radiology"},{"key":"1773_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/0284185113495836","volume":"55","author":"Y Hayashida","year":"2014","unstructured":"Hayashida Y, Kakeda S, Hiai Y, Ide S, Ogasawara A, Ooki H, et al. Diagnosis of intracranial hemorrhagic lesions: comparison between 3D-SWAN (3D T2*-weighted imaging with multi-echo acquisition) and 2D\u2013T2*-weighted imaging. Acta Radiol. 2014;55:201\u20137. https:\/\/doi.org\/10.1177\/0284185113495836.","journal-title":"Acta Radiol"},{"key":"1773_CR21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.acra.2007.12.021","volume":"15","author":"Y Hiai","year":"2008","unstructured":"Hiai Y, Kakeda S, Sato T, Ohnari N, Moriya J, Kitajima M, et al. 3D TOF MRA of intracranial aneurysms at 1.5 T and 3 T: influence of matrix, parallel imaging, and acquisition time on image quality: a vascular phantom study. Acad Radiol. 2008;15:635\u201340. https:\/\/doi.org\/10.1016\/j.acra.2007.12.021.","journal-title":"Acad Radiol"},{"key":"1773_CR22","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1007\/s00330-022-09265-6","volume":"33","author":"ALM Goncalves Filho","year":"2023","unstructured":"Goncalves Filho ALM, Awan KM, Conklin J, Ngamsombat C, Cauley SF, Setsompop K, et al. Validation of a highly accelerated post-contrast wave-controlled aliasing in parallel imaging (CAIPI) 3D\u2013T1 MPRage compared to standard 3D\u2013T1 MPRage for detection of intracranial enhancing lesions on 3-T MRI. Eur Radiol. 2023;33:2905\u201315. https:\/\/doi.org\/10.1007\/s00330-022-09265-6.","journal-title":"Eur Radiol"},{"key":"1773_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00234-024-03304-3","volume":"66","author":"V Schultz","year":"2024","unstructured":"Schultz V, Hedderich DM, Schmitz-Koep B, Schinz D, Zimmer C, Yakushev I, et al. Removing outliers from the normative database improves regional atrophy detection in single-subject voxel-based morphometry. Neuroradiology. 2024;66:507\u201319. https:\/\/doi.org\/10.1007\/s00234-024-03304-3.","journal-title":"Neuroradiology"},{"key":"1773_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2463\/mrms.mp.2023-0093","volume":"24","author":"S Inui","year":"2025","unstructured":"Inui S, Kaneda D, Sakurai K, Uchida Y, Abe O, Hashizume Y. Voxel-based morphometry of Alzheimer\u2019s disease using a localizer image: a comparative study with magnetization prepared rapid acquisition with gradient echo. Magn Reson Med Sci. 2025;24:103\u201311. https:\/\/doi.org\/10.2463\/mrms.mp.2023-0093.","journal-title":"Magn Reson Med Sci"},{"key":"1773_CR25","doi-asserted-by":"publisher","DOI":"10.2463\/mrms.mp.2023-0124","author":"M Goto","year":"2024","unstructured":"Goto M, Kamagata K, Andica C, Takabayashi K, Uchida W, Goto T, et al. Deep learning-based hierarchical brain segmentation with preliminary analysis of the repeatability and reproducibility. Magn Reson Med Sci. 2024. https:\/\/doi.org\/10.2463\/mrms.mp.2023-0124.","journal-title":"Magn Reson Med Sci"},{"key":"1773_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2463\/mrms.rev.2024-0053","volume":"23","author":"SR Das","year":"2024","unstructured":"Das SR, Ilesanmi A, Wolk DA, Gee JC. Beyond macrostructure: is there a role for radiomics analysis in neuroimaging? Magn Reson Med Sci. 2024;23:367\u201376. https:\/\/doi.org\/10.2463\/mrms.rev.2024-0053.","journal-title":"Magn Reson Med Sci"},{"key":"1773_CR27","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1007\/s00234-022-03028-2","volume":"64","author":"HG Kim","year":"2022","unstructured":"Kim HG, Oh SW, Han D, Kim JY, Lim GY. Accelerated 3D T2-weighted images using compressed sensing for pediatric brain imaging. Neuroradiology. 2022;64:2399\u2013407. https:\/\/doi.org\/10.1007\/s00234-022-03028-2.","journal-title":"Neuroradiology"},{"key":"1773_CR28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2463\/mrms.mp.2022-0112","volume":"23","author":"M Iwamura","year":"2024","unstructured":"Iwamura M, Ide S, Sato K, Kakuta A, Tatsuo S, Nozaki A, et al. Thin-slice two-dimensional T2-weighted imaging with deep learning-based reconstruction: improved lesion detection in the brain of patients with multiple sclerosis. Magn Reson Med Sci. 2024;23:184\u201392. https:\/\/doi.org\/10.2463\/mrms.mp.2022-0112.","journal-title":"Magn Reson Med Sci"},{"key":"1773_CR29","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.acra.2023.05.010","volume":"31","author":"A Estler","year":"2024","unstructured":"Estler A, Hauser TK, Mengel A, Brunn\u00e9e M, Zerweck L, Richter V, et al. Deep learning accelerated image reconstruction of fluid-attenuated inversion recovery sequence in brain imaging: reduction of acquisition time and improvement of image quality. Acad Radiol. 2024;31:180\u20136. https:\/\/doi.org\/10.1016\/j.acra.2023.05.010.","journal-title":"Acad Radiol"},{"key":"1773_CR30","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s11604-023-01415-0","volume":"41","author":"Y Saito","year":"2023","unstructured":"Saito Y, Kamagata K, Andica C, Uchida W, Takabayashi K, Yoshida S, et al. Reproducibility of automated calculation technique for diffusion tensor image analysis along the perivascular space. Jpn J Radiol. 2023;41:947\u201354. https:\/\/doi.org\/10.1007\/s11604-023-01415-0.","journal-title":"Jpn J Radiol"},{"key":"1773_CR31","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1007\/s11604-023-01432-z","volume":"41","author":"Y Saito","year":"2023","unstructured":"Saito Y, Kamagata K, Andica C, Taoka T, Tuerxun R, Uchida W, et al. Multisite harmonization of diffusion tensor image analysis along the perivascular space using the COMBined association test. Jpn J Radiol. 2023;41:1072\u201383. https:\/\/doi.org\/10.1007\/s11604-023-01432-z.","journal-title":"Jpn J Radiol"},{"key":"1773_CR32","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00234-024-03290-6","volume":"66","author":"YLL Lai","year":"2024","unstructured":"Lai YLL, Hsu FT, Yeh SY, Kuo YT, Lin HH, Lin YC, et al. Atrophy of the cholinergic regions advances from early to late mild cognitive impairment. Neuroradiology. 2024;66:543\u201356. https:\/\/doi.org\/10.1007\/s00234-024-03290-6.","journal-title":"Neuroradiology"},{"key":"1773_CR33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00234-024-03280-8","volume":"66","author":"MMJ Wittens","year":"2024","unstructured":"Wittens MMJ, Allemeersch GJ, Sima DM, Vanderhasselt T, Raeymaeckers S, Fransen E, et al. Towards validation in clinical routine: a comparative analysis of visual MTA ratings versus the automated ratio between inferior lateral ventricle and hippocampal volumes in Alzheimer\u2019s disease diagnosis. Neuroradiology. 2024;66:487\u2013506. https:\/\/doi.org\/10.1007\/s00234-024-03280-8.","journal-title":"Neuroradiology"},{"key":"1773_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89:88\u2013100. https:\/\/doi.org\/10.1212\/WNL.0000000000004058.","journal-title":"Neurology"},{"key":"1773_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00234-024-03502-z","volume":"67","author":"K Sakurai","year":"2025","unstructured":"Sakurai K, Kaneda D, Morimoto S, Uchida Y, Inui S, Shang C, et al. Medial temporal atrophy predicts the limbic comorbidities in lewy body disease. Neuroradiology. 2025;67:65\u201377. https:\/\/doi.org\/10.1007\/s00234-024-03502-z.","journal-title":"Neuroradiology"},{"key":"1773_CR36","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/nan.12250","volume":"41","author":"T Lashley","year":"2015","unstructured":"Lashley T, Rohrer JD, Mead S, Revesz T. Review: an update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations. Neuropathol Appl Neurobiol. 2015;41:858\u201381. https:\/\/doi.org\/10.1111\/nan.12250.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1773_CR37","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s00234-024-03432-w","volume":"66","author":"K Sakurai","year":"2024","unstructured":"Sakurai K, Tokumaru AM, Yoshida M, Saito Y, Wakabayashi K, Komori T, et al. Conventional magnetic resonance imaging key features for distinguishing pathologically confirmed corticobasal degeneration from its mimics: a retrospective analysis of the J-VAC study. Neuroradiology. 2024;66:1917\u201329. https:\/\/doi.org\/10.1007\/s00234-024-03432-w.","journal-title":"Neuroradiology"},{"key":"1773_CR38","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/WAD.0000000000000034","volume":"28","author":"P Sachdev","year":"2014","unstructured":"Sachdev P, Kalaria R, O\u2019Brien J, Skoog I, Alladi S, Black SE, et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014;28:206\u201318. https:\/\/doi.org\/10.1097\/WAD.0000000000000034.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1773_CR39","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1007\/s00234-024-03464-2","volume":"66","author":"M Quintas-Neves","year":"2024","unstructured":"Quintas-Neves M, Almeida FC, Gauthreaux K, Teylan MA, Mock CN, Kukull WA, et al. Fazekas scale magnetic resonance imaging assessment in Alzheimer\u2019s disease and primary age-related tauopathy. Neuroradiology. 2024;66:2185\u201393. https:\/\/doi.org\/10.1007\/s00234-024-03464-2.","journal-title":"Neuroradiology"},{"key":"1773_CR40","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/jnnp-2017-317557","volume":"90","author":"NS Graham","year":"2019","unstructured":"Graham NS, Sharp DJ. Understanding neurodegeneration after traumatic brain injury: from mechanisms to clinical trials in dementia. J Neurol Neurosurg Psychiatry. 2019;90:1221\u201333. https:\/\/doi.org\/10.1136\/jnnp-2017-317557.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1773_CR41","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1093\/brain\/awaa316","volume":"143","author":"NSN Graham","year":"2020","unstructured":"Graham NSN, Jolly A, Zimmerman K, Bourke NJ, Scott G, Cole JH, et al. Diffuse axonal injury predicts neurodegeneration after moderate-severe traumatic brain injury. Brain. 2020;143:3685\u201398. https:\/\/doi.org\/10.1093\/brain\/awaa316.","journal-title":"Brain"},{"key":"1773_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.wneu.2023.12.094","volume":"183","author":"M Tullberg","year":"2024","unstructured":"Tullberg M, Toma AK, Yamada S, Laurell K, Miyajima M, Watkins LD, et al. Classification of chronic hydrocephalus in adults: a systematic review and analysis. World Neurosurg. 2024;183:113\u201322. https:\/\/doi.org\/10.1016\/j.wneu.2023.12.094.","journal-title":"World Neurosurg"},{"key":"1773_CR43","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","volume":"21","author":"A Charidimou","year":"2022","unstructured":"Charidimou A, Boulouis G, Frosch MP, Baron JC, Pasi M, Albucher JF, et al. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol. 2022;21:714\u201325. https:\/\/doi.org\/10.1016\/S1474-4422(22)00208-3.","journal-title":"Lancet Neurol"},{"key":"1773_CR44","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s13244-014-0312-x","volume":"5","author":"K Sakurai","year":"2014","unstructured":"Sakurai K, Tokumaru AM, Nakatsuka T, Murayama S, Hasebe S, Imabayashi E, et al. Imaging spectrum of sporadic cerebral amyloid angiopathy: multifaceted features of a single pathological condition. Insights Imaging. 2014;5:375\u201385. https:\/\/doi.org\/10.1007\/s13244-014-0312-x.","journal-title":"Insights Imaging"},{"key":"1773_CR45","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1136\/jnnp-2013-306084","volume":"85","author":"J Sone","year":"2014","unstructured":"Sone J, Kitagawa N, Sugawara E, Iguchi M, Nakamura R, Koike H, et al. Neuronal intranuclear inclusion disease cases with leukoencephalopathy diagnosed via skin biopsy. J Neurol Neurosurg Psychiatry. 2014;85:354\u20136. https:\/\/doi.org\/10.1136\/jnnp-2013-306084.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1773_CR46","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2214\/AJR.07.2424","volume":"189","author":"SL Stuckey","year":"2007","unstructured":"Stuckey SL, Goh TD, Heffernan T, Rowan D. Hyperintensity in the subarachnoid space on FLAIR MRI. AJR Am J Roentgenol. 2007;189:913\u201321. https:\/\/doi.org\/10.2214\/AJR.07.2424.","journal-title":"AJR Am J Roentgenol"},{"key":"1773_CR47","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2214\/ajr.159.3.1503032","volume":"159","author":"D Le Bihan","year":"1992","unstructured":"Le Bihan D, Turner R, Douek P, Patronas N. Diffusion MR imaging: clinical applications. AJR Am J Roentgenol. 1992;159:591\u20139. https:\/\/doi.org\/10.2214\/ajr.159.3.1503032.","journal-title":"AJR Am J Roentgenol"},{"key":"1773_CR48","doi-asserted-by":"publisher","first-page":"562","DOI":"10.2214\/AJR.22.28461","volume":"220","author":"M Roytman","year":"2023","unstructured":"Roytman M, Mashriqi F, Al-Tawil K, Schulz PE, Zaharchuk G, Benzinger TLS, et al. Amyloid-related imaging abnormalities: an update. AJR Am J Roentgenol. 2023;220:562\u201374. https:\/\/doi.org\/10.2214\/AJR.22.28461.","journal-title":"AJR Am J Roentgenol"},{"key":"1773_CR49","doi-asserted-by":"publisher","DOI":"10.1148\/rg.230009","volume":"43","author":"A Agarwal","year":"2023","unstructured":"Agarwal A, Gupta V, Brahmbhatt P, Desai A, Vibhute P, Joseph-Mathurin N, et al. Amyloid-related imaging abnormalities in Alzheimer disease treated with anti-amyloid-\u03b2 therapy. Radiographics. 2023;43: e230009. https:\/\/doi.org\/10.1148\/rg.230009.","journal-title":"Radiographics"},{"key":"1773_CR50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1148\/radiol.2021203071","volume":"299","author":"S Haller","year":"2021","unstructured":"Haller S, Haacke EM, Thurnher MM, Barkhof F. Susceptibility-weighted imaging: technical essentials and clinical neurologic applications. Radiology. 2021;299:3\u201326. https:\/\/doi.org\/10.1148\/radiol.2021203071.","journal-title":"Radiology"},{"key":"1773_CR51","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1067\/j.cpradiol.2006.04.002","volume":"35","author":"Y Tsushima","year":"2006","unstructured":"Tsushima Y, Endo K. Hypointensities in the brain on T2*-weighted gradient-echo magnetic resonance imaging. Curr Probl Diagn Radiol. 2006;35:140\u201350. https:\/\/doi.org\/10.1067\/j.cpradiol.2006.04.002.","journal-title":"Curr Probl Diagn Radiol"},{"key":"1773_CR52","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00062-022-01231-5","volume":"33","author":"S Weidauer","year":"2023","unstructured":"Weidauer S, Neuhaus E, Hattingen E. Cerebral superficial siderosis: etiology, neuroradiological features and clinical findings. Clin Neuroradiol. 2023;33:293\u2013306. https:\/\/doi.org\/10.1007\/s00062-022-01231-5.","journal-title":"Clin Neuroradiol"},{"key":"1773_CR53","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.acra.2010.02.014","volume":"17","author":"S Kakeda","year":"2010","unstructured":"Kakeda S, Korogi Y, Ohnari N, Nishimura J, Moriya J, Yamamoto J, et al. Superficial siderosis associated with a chronic subdural hematoma: T2-weighted MR imaging at 3T. Acad Radiol. 2010;17:871\u20136. https:\/\/doi.org\/10.1016\/j.acra.2010.02.014.","journal-title":"Acad Radiol"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-025-01773-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-025-01773-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-025-01773-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T02:53:38Z","timestamp":1753325618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11604-025-01773-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1773"],"URL":"https:\/\/doi.org\/10.1007\/s11604-025-01773-x","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"10 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}